[1] Xu X J,Araki K,Li S Z,et al. Autophagy is essential for effector CD8(+) T cell survival and memory formation[J].Nat Immunol,2014,15(12):1152
[2] Rao S,Yang H,Penninger J M,et al. Autophagy in non-small cell lung carcinogenesis:A positive regulator of antitumor immunosurveillance [J].Autophagy,2014,10(3):529
[3] Chen M,Hong M J,Sun H H,et al. Essential role for autophagy in the maintenance of immunological memory against influenza infection[J]. Nat Med,2014,20(5):507
[4] Hanahan D,Weinberg R A. Hallmarks of cancer: the next Generation[J]. Cell,2011,144(5):646
[5] Galluzzi L,Pietrocola F,Levine B,et al. Metabolic control of autophagy[J].Cell,2014,159(6):1263
[6] Umemura A,He F,Taniguchi K,et al. p62,upregulated during preneoplasia,induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-Initiating cells[J].Cancer Cell,2016,29(6):935
[7] Dou Z X,Xu C Y,Donahue G,et al. Autophagy mediates degradation of nuclear lamina[J].Nature,2015,527(7576):105
[8] Perera R M,Stoykova S,Nicolay B N,et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism[J]. Nature,2015,524(7565):361
[9] Ladoire S,Enot D,Senovilla L,et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer[J]. Autophagy,2016,12(5):864
[10] Ma Y T,Galluzzi L,Zitvogel L,et al.Autophagy and cellular immune responses[J].Immunity,2013,39(2):211
[11] Shibutani S T,Saitoh T,Nowag H,et al. Autophagy and autophagy-related proteins in the immune system[J].Nat Immunol,2015,16(10):1014
[12] Li B,Lei Z,Lichty B D,et al. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-gamma in B16 melanoma cells[J].Cancer Immunol Immunother,2010,59(2):313
[13] Ma C,Kesarwala A H,Eggert T,et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis[J].Nature,2016,531(7593):253
[14] Pengo N,Scolari M,Oliva L,et al. Plasma cells require autophagy for sustainable immunoglobulin production[J].Nat Immunol,2013, 14(3):298
[15] Sharma P,Allison J P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential[J]. Cell,2015,161(2):205.
[16] Shalapour S,Immunity K M.Inflammation,and cancer:an eternal fight between good and evil[J].J Clin Invest,2015,125(9):3347
[17] Bezu L,Gomes-De-Silva L C,Dewitte H A,et al.Combinatorial strategies for the induction of immunogenic cell death[J].Front Immunol,2015,6:187
[18] Kroemer G,Galluzzi L,Kepp O,et al. Immunogenic cell death in cancer therapy[J]. Annu Rev Immunol,2013,31:51
[19] Twyman-Saint Victor C,Rech A J,Maity A,et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer[J]. Nature,2015,520(7547):373
[20] Kaufman H L,Kohlhapp F J,Zloza A. Oncolytic viruses: a new class of immunotherapy drugs[J]. Nat Rev Drug Discov,2015,14(9):642
[21] Krysko D V,Garg A D,Kaczmarek A A,et al. Immunogenic cell death and DAMPs in cancer therapy[J].Nat Rev Cancer,2012, 12(12):860
[22] Michaud M,Martins I,Sukkurwala A Q,et al. Autophagy-Dependent anticancer immune responses induced by chemotherapeutic agents in mice[J]. Science,2011,334(662):1573
[23] Pfirschke C,Engblom C,Rickelt S,et al. Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy[J]. Immunity,2016,44(2):343
[24] Ladoire S,Penault-Llorca F,Senovilla L A,et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer[J]. Autophagy,2015,11(10):1878
[25] Ramakrishnan R,Huang C,Cho H I,et al. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy[J].Cancer Res,2012,72(21):5483
[26] Kim S,Ramakrishnan R,Lavilla-Alonso S A,et al. Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice[J].Cancer Immunol Immunother,2014,63(10):1009
[27] Martins I,Wang Y,Michaud M,et al. Molecular mechanisms of ATP secretion during immunogenic cell death[J]. Cell Death Differ,2014, 21(1,SI):79
[28] White E. The role for autophagy in cancer[J].J Clin Inves,2015, 125(1):42
[29] Eng C H,Wang Z C,Tkach D,et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy[J].Proc Natl Acad Sci U S A,2016,113(1):182
[30] Robert C,Long G V,Brady B,et al. Nivolumab in previously untreated melanoma without BRAF mutation[J].N Engl J Med,2015, 372(4):320
[31] Bhullar K S,Hubbard B P. Lifespan and healthspan extension by resveratrol[J].Biochim Biophys Acta Mole Basis Dis,2015,1852(6):1209
[32] Zhong Z Y,Umemura A,Sanchez-Lopez E,et al. NF-kappa B Restricts Inflammasome Activation via Elimination of Damaged Mitochondria[J]. Cell,2016,164(5):896
[1]孙亚军,傅正,朱志峰,等.基因芯片分析三肽化合物酪丝亮肽对人肝癌基因表达谱的影响[J].天津医科大学学报,2013,19(05):353.
[2]李 杨,齐建利,赵立平,等.xCT影响肝癌细胞转移的作用机制研究[J].天津医科大学学报,2014,20(02):93.
LI Yang,QI Jian-li,ZHAO Li-ping,et al.Molecular mechanism of metastasis in hepatocellular carcinoma inhibited by xCT[J].Journal of Tianjin Medical University,2014,20(02):93.
[3]王 勇,陈雅婧 综述,岳 丹审校.YB-1对肿瘤增殖调控的研究进展[J].天津医科大学学报,2014,20(04):332.
[4]叶剑飞 综述. microRNAs与肿瘤研究的新进展[J].天津医科大学学报,2014,20(05):416.
[5]孙秀梅,张 飞 综 述,牛瑞芳 审校. Nanog及其假基因NanogP8在肿瘤中的研究进展[J].天津医科大学学报,2015,21(03):90.
[6]孙秀梅,张 飞 综 述,牛瑞芳 审校. Nanog及其假基因NanogP8在肿瘤中的研究进展[J].天津医科大学学报,2015,21(01):90.
[7]黄 纯 综述,李 凯 审校. 肿瘤免疫治疗与化疗的协同效应研究现状[J].天津医科大学学报,2015,21(04):363.
[8]孔令平,周 旋 综述,张 仑 审校.长链非编码RNA MALAT1在肿瘤中的研究进展[J].天津医科大学学报,2015,21(04):367.
[9]郭小凡 综述,邓靖宇,梁 寒 审校.PCDH10启动子甲基化与恶性肿瘤关系的研究进展[J].天津医科大学学报,2016,22(02):182.
[10]宋 虎,王 振,杜晨阳,等.肝缺血再灌注损伤过程中细胞自噬的研究进展[J].天津医科大学学报,2018,24(01):87.